Screen Reader Access   

Patent Licensing Details

Technology reference number: PCT/IN2019/050718
First Published on: NA
Title of the technology: A pharmaceutical composition for the treatment of TH17 cells mediated autoimmune diseases
Technology Brief: NA
Potential Application(s): NA
Advantage(s): NA
IP status: PCT application
Development status: Proof of Concept
Researcher(s): NA
Owner(s): THSTI
Last date to receive interest:
Image(s): NA